CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again
HONG KONG, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – China Resources Pharmaceutical Group Limited (“CR Pharmaceutical” or the “Group”) (stock code: 3320) has announced that the Group will […]